We are looking for children 2 to 17 years of age to join a Crohn’s disease (CD) research study to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderately to severely active IBD (including associated symptoms such as cramping, growth failure, bloody stool, chronic fatigue and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Act now.
